Nelly Firmin

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas

François Le Loarer, Sarah Watson, Gaëlle Pierron et al. · Nature Genetics · 2015 · 350 citations

Malignant Disease, Medicine, Cancer Cell Biology +11

Surgery in reference centers improves survival of sarcoma patients: a nationwide study

Jean‐Yves Blay, Charles Honoré, Eberhard Stoeckle et al. · Annals of Oncology · 2019 · 307 citations · Full text

Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases

William Jacot, Elvire Pons‐Tostivint, Jean‐Sébastien Frenel et al. · Breast Cancer Research and Treatment · 2016 · 117 citations

Breast Oncology, Brain Metastases, Medicine +8

Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial

Patricia Pautier, Antoîne Italiano, Sophie Piperno‐Neumann et al. · The Lancet Oncology · 2022 · 110 citations

Unresectable Leiomyosarcoma, First-line Therapy, Surgical Oncology +7

Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma

Patricia Pautier, Antoîne Italiano, Sophie Piperno‐Neumann et al. · New England Journal of Medicine · 2024 · 68 citations · Full text